Advanced search
Publication Cover
Expert Review of Endocrinology & Metabolism Volume 8, 2013 - Issue 2
Submit an article Journal homepage
968
Views
8
CrossRef citations to date
0
Altmetric
Drug Profile

Efficacy and safety of lixisenatide in the treatment of Type 2 diabetes mellitus: a review of Phase III clinical data

Denis Raccah Department of Diabetology, University Hospital Sainte Marguerite, 270 Boulevard de Sainte Marguerite, 13009 Marseille, France. [email protected]
Pages 105-121 | Published online: 10 Jan 2014

Citations (8)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Denis Raccah. (2014) Lixisenatide once daily significantly improves post-prandial glucose throughout the day due to diverse mechanistic effects. Expert Review of Endocrinology & Metabolism 9:3, pages 201-203.
Read now
Morten Donsmark & Lotte Bjerre Knudsen. (2014) Lixisenatide in the treatment of Type 2 diabetes. Expert Review of Endocrinology & Metabolism 9:3, pages 197-199.
Read now

Articles from other publishers (6)

Michaela Luconi, Giulia Cantini, Antonio Ceriello & Edoardo Mannucci. (2017) Perspectives on cardiovascular effects of incretin-based drugs: From bedside to bench, return trip. International Journal of Cardiology 241, pages 302-310.
Crossref
Fabio Broglio, Edoardo Mannucci, Raffaele Napoli, Antonio Nicolucci, Francesco Purrello, Elena Nikonova, William Stager & Roberto Trevisan. (2017) Beneficial effect of lixisenatide after 76 weeks of treatment in patients with type 2 diabetes mellitus: A meta-analysis from the GetGoal programme. Diabetes, Obesity and Metabolism 19:2, pages 248-256.
Crossref
Francesco Giorgino, Riccardo C. Bonadonna, Sandro Gentile, Roberto Vettor & Paolo Pozzilli. (2016) Treatment intensification in patients with inadequate glycemic control on basal insulin: rationale and clinical evidence for the use of short‐acting and other glucagon‐like peptide‐1 receptor agonists. Diabetes/Metabolism Research and Reviews 32:6, pages 497-511.
Crossref
Ulrich Werner. (2014) Effects of the GLP-1 receptor agonist lixisenatide on postprandial glucose and gastric emptying – preclinical evidence. Journal of Diabetes and its Complications 28:1, pages 110-114.
Crossref
Cornelia Jaursch-Hancke. (2013) Positive Daten aus klinischem Phase-III-Studienprogramm. Info Diabetologie 7:5, pages 26-27.
Crossref
Martin Lorenz, Andreas Evers & Michael Wagner. (2013) Recent progress and future options in the development of GLP-1 receptor agonists for the treatment of diabesity. Bioorganic & Medicinal Chemistry Letters 23:14, pages 4011-4018.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.